Search Results - "Basson, Bruce"
-
1
Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial
Published in The Lancet (British edition) (16-06-2012)“…Summary Background Glycaemic control deteriorates progressively over time in patients with type 2 diabetes. Options for treatment escalation remain…”
Get full text
Journal Article -
2
Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial
Published in Critical care medicine (01-03-2003)“…OBJECTIVETo assess morbidity in patients with severe sepsis managed with and without drotrecogin alfa (activated). DESIGNAnalysis of secondary end points in a…”
Get full text
Journal Article -
3
Long-term olanzapine treatment : Weight change and weight-related health factors in schizophrenia
Published in The journal of clinical psychiatry (01-02-2001)“…Weight change and the weight-related health factors of nonfasting serum glucose, serum cholesterol, and diastolic blood pressure levels were analyzed in…”
Get full text
Journal Article -
4
Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia
Published in Blood (01-11-2003)“…Sepsis is associated with systemic inflammation, coagulopathy, and disrupted protein C (PC) pathway function. The effect of prothrombotic polymorphism, factor…”
Get full text
Journal Article -
5
Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis
Published in Critical care medicine (01-01-2003)“…OBJECTIVETo assess the cost-effectiveness of drotrecogin alfa (activated) therapy, which was recently shown to reduce mortality in severe sepsis…”
Get full text
Journal Article -
6
Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone
Published in The journal of clinical psychiatry (01-04-2001)“…Clinical factors predicting weight change in patients with schizophrenia and related disorders during acute treatment with the antipsychotic drugs olanzapine,…”
Get full text
Journal Article -
7
Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial
Published in Intensive care medicine (01-06-2003)“…Based on the results of the PROWESS trial the European Agency for the Evaluation of Medicinal Products has recently approved drotrecogin alfa (activated) for…”
Get full text
Journal Article -
8
The Effect of Raloxifene after Discontinuation of Long-Term Alendronate Treatment of Postmenopausal Osteoporosis
Published in The journal of clinical endocrinology and metabolism (01-03-2006)“…Objective: The aim of this study was to compare bone mineral density (BMD) and biochemical markers of bone turnover in patients receiving long-term alendronate…”
Get full text
Journal Article -
9
Drotrecogin alfa (activated) (recombinant human activated protein C) reduces host coagulopathy response in patients with severe sepsis
Published in Thrombosis and haemostasis (01-10-2003)“…Drotrecogin alfa (activated) improved survival in patients with severe sepsis in PROWESS, a double-blind, study of 1690 adult patients randomized to…”
Get more information
Journal Article -
10
Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients
Published in International clinical psychopharmacology (01-01-2005)“…The present study examined sexual functioning among first-time treated schizophrenia patients at the time that they initiated antipsychotic treatment, and…”
Get full text
Journal Article -
11
Efficacy and Treatment Satisfaction with On-Demand Tadalafil (Cialis ®) in Men with Erectile Dysfunction
Published in European urology (01-09-2004)“…Objective: Tadalafil (Cialis ®) is an inhibitor of phosphodiesterase type 5, which mediates relaxation of vascular smooth muscle in the corpus cavernosum thus…”
Get full text
Journal Article -
12
Effects of Once‐Daily Tadalafil on Treatment Satisfaction, Psychosocial Outcomes, Spontaneous Erections, and Measures of Endothelial Function in Men With Erectile Dysfunction But Naive to Phosphodiesterase Type 5 Inhibitors
Published in Journal of andrology (01-11-2012)“…: Previous studies established the efficacy of once‐daily tadalafil for men with erectile dysfunction. However, no trial has focused on the effects of such…”
Get full text
Journal Article -
13
A randomized phase II trial of sequential gemcitabine plus vinorelbine followed by gemcitabine plus ifosfamide versus gemcitabine plus cisplatin in the treatment of chemo-naive patients with stages III and IV non-small cell lung cancer (NSCLC)
Published in Lung cancer (Amsterdam, Netherlands) (01-08-2007)“…Summary Background Third-generation platinum-based combinations are established as first-line treatment for advanced non-small cell lung cancer (NSCLC)…”
Get full text
Journal Article -
14
Strategies for switching from conventional antipsychotic drugs or risperidone to olanzapine
Published in The journal of clinical psychiatry (01-11-2000)“…This study compared the efficacy and safety of 4 therapeutically relevant strategies for switching clinically stable patients from a conventional antipsychotic…”
Get full text
Journal Article -
15
Is there a real difference between the first onset of efficacy for atypical antipsychotic monotherapies in acute bipolar mania?
Published in The journal of clinical psychiatry (01-10-2005)Get full text
Journal Article -
16
The Comparative Peripheral Anticholinergic-Like Adverse Event Profiles of Olanzapine and Risperidone
Published in Primary care companion to the Journal of clinical psychiatry (01-08-2000)“…OBJECTIVE: To test the hypothesis that reported in vitro muscarinic receptor affinity differences between olanzapine and risperidone would be reflected in…”
Get full text
Journal Article -
17
Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]
Published in Critical care (London, England) (01-04-2004)“…PROWESS (Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis) was a phase III, randomized, double blind, placebo controlled,…”
Get full text
Journal Article -
18
-
19
Efficacy and Treatment Satisfaction with on-demand Tadalafil (Cialis®) in men with erectile dysfunction. Commentary
Published in European urology (2004)Get full text
Journal Article -
20